There are certain statements that should stop a conversation cold. This is one of them. In May 2021, Dr. Anthony Fauci told Congress it was impossible to guarantee that researchers at the Wuhan Institute of Virology did not use American funds to perform gain-of-function research on coronaviruses. He was answering a narrow question. No funding agency can absolutely guarantee that a grantee never lied or never violated the terms of a grant. That distinction matters, and anyone who claims the quote alone proves a cover-up is going too far.

But what he did acknowledge should still have generated extraordinary scrutiny. American taxpayer money went through EcoHealth Alliance to the Wuhan Institute of Virology. Researchers there studied bat coronaviruses. Some of that work involved combining naturally occurring bat coronaviruses with other coronavirus components to build chimeric viruses. The pandemic then emerged in Wuhan. Federal auditors later found serious deficiencies in how the grants were monitored. China refused to hand over laboratory information investigators said they needed. Six years later, the origin of SARS-CoV-2 is still unresolved.

The man who ran the federal infectious-disease agency behind the funding could not guarantee the foreign lab actually followed the rules attached to American money. That does not prove a laboratory accident. It proves that asking hard questions was never crazy.

First, What Is Gain-of-Function Research?

Part of the problem in this debate is that "gain of function" gets used so loosely that two people can say the same words and mean two different things. In the broad scientific sense it means altering an organism to give it some new or enhanced biological property. Plenty of that work is ordinary and useful. The concern gets serious when researchers alter a pathogen in ways that could make it more transmissible or more dangerous. A virus that spreads poorly on its own can be pushed through genetic changes or repeated passage until it infects hosts more efficiently.

There can be legitimate reasons to do this. Scientists may want to anticipate how a virus could evolve, test vaccines ahead of a mutation or identify dangerous traits before nature produces them on its own. But the obvious problem is just as simple. What happens when the experiment works too well? You can start with a limited threat and finish with something considerably more dangerous. That is the dual-use problem, and it is why federal officials have spent more than a decade arguing over where legitimate research ends and unacceptable risk begins.

Why Was Some Gain-of-Function Research Paused?

Contrary to the political shorthand, the United States never simply outlawed gain-of-function research. In October 2014, the federal government paused funding for certain experiments involving influenza, MERS and SARS viruses that could reasonably be expected to increase pathogenicity or respiratory transmissibility in mammals. NIH's own documentation describes the pause in those terms.

The reasoning was straightforward. A lab accident involving an ordinary chemical might injure a handful of people. A lab accident involving a newly enhanced respiratory pathogen could move beyond the lab, beyond the city and beyond the country. This was never "science good" against "science bad." It was a risk-versus-benefit calculation. Researchers argued the work could help humanity prepare for emerging pathogens. Critics argued that deliberately enhancing a potential pandemic pathogen creates a small chance of a catastrophic outcome.

Whatever you think of the politics around that decision, the underlying biosafety concern is real.

Then We Get to Wuhan

This is where the discussion stops being theoretical. The Government Accountability Office reviewed federal funding tied to Chinese research institutions and found that the Wuhan Institute of Virology received subawards through EcoHealth Alliance under an NIH grant called Understanding the Risk of Bat Coronavirus Emergence. According to GAO, that work included genetic experiments combining naturally occurring bat coronaviruses with SARS and MERS viruses to produce hybridized strains.

Read that carefully. It does not mean researchers created SARS-CoV-2. NIH later concluded the specific bat viruses involved in the federally funded work were genetically too distant from SARS-CoV-2 to be its direct source. That fact matters, and it should not be buried simply because it complicates the lab-leak argument. But another fact should not be buried either. Scientists at the Wuhan Institute of Virology really were conducting experiments on genetically altered bat coronaviruses. That is no longer speculation.

The dispute became largely a fight over terminology and regulatory classification. Did these specific experiments meet the government's technical definition of prohibited or specially regulated gain-of-function research? NIAID concluded in 2016 that the chimeric-virus work did not fall under the 2014 pause because officials did not expect it to increase pathogenicity or transmissibility. But the agency was concerned enough to require researchers to stop and report if viral growth crossed a specified threshold.

The Oversight System Did Not Work the Way Americans Were Entitled to Expect

The HHS Office of Inspector General later audited NIH's relationship with EcoHealth Alliance. Its conclusion was hardly reassuring. The inspector general found that NIH did not effectively monitor EcoHealth's compliance with several requirements, and that EcoHealth itself failed important monitoring and reporting duties. One progress report arrived nearly two years late. NIH did not follow up on the missing report promptly, and when it finally surfaced it showed virus growth meeting a benchmark that should have triggered notice. GAO separately found that EcoHealth violated an award condition by failing to immediately report that mice infected with a genetically altered bat coronavirus grew sicker than the comparison group.

None of that proves SARS-CoV-2 came from that experiment. But look at the chain. American taxpayers fund EcoHealth. EcoHealth funds research at Wuhan. The research involves modified bat coronaviruses. Special reporting requirements exist because the results could be concerning. Concerning results are not promptly reported. Federal monitoring is deficient. Wuhan later refuses to hand over information investigators request. Then a coronavirus pandemic begins in the same city.

Fauci's Statement Exposes the Weak Link

This is where Fauci's admission actually matters. When asked whether the Wuhan lab could have violated the conditions attached to American money, he acknowledged the obvious. A funding agency cannot guarantee that a foreign grantee is telling the truth. On its own that is almost mundane. Of course you cannot guarantee that every recipient of government money follows every rule.

But we were not discussing a landscaping grant. We were discussing coronavirus research in Wuhan, where the entire regulatory system depended on investigators reporting accurately and flagging unexpected results when required. Federal audits later documented exactly the kind of monitoring and reporting failures that make Fauci's concession important. If an experiment is dangerous enough to require special reporting, "we trusted the grantee" is not an adequate safety system.

Trust is not verification. A paperwork requirement is not biosafety. A grant condition Washington cannot independently enforce inside a Chinese laboratory is not meaningful protection against a catastrophic accident.

That should be one of the lasting lessons of this entire episode regardless of where SARS-CoV-2 ultimately came from.

What About the Wet Market?

This is where both sides need more precision. For years the public got a simple story. A wild animal was infected. That animal reached the Huanan Seafood Wholesale Market. Someone was infected there. COVID spread around the world. Case closed. Except the case is not closed, and the strongest argument today is not that the wet-market evidence disappeared. It has not. A 2024 study in the journal Cell found genetic material from susceptible wildlife, including raccoon dogs, civets and bamboo rats, in environmental samples from market stalls where SARS-CoV-2 was also detected. The World Health Organization's independent SAGO group concluded in 2025 that the weight of current scientific evidence favors zoonotic spillover.

If we demand honesty from Fauci, NIH, EcoHealth and China, we owe the same honesty to the evidence supporting the competing hypothesis. But here is the part that gets left out.

That is a long way from "we know it came from the wet market."

The Intelligence Community Isn't Settled Either

The picture gets even less tidy once you bring in intelligence assessments. In January 2025 the CIA said a research-related origin was more likely than a natural one, though the agency stressed low confidence in that judgment and said both scenarios remain plausible. Low confidence matters. It means this is not proof. Intelligence analysis is also a different discipline from peer-reviewed science. Agencies may have access to information scientists do not have, while scientists weigh genomic and epidemiological evidence differently.

That is why I reject both extremes. It is premature to declare the lab leak proven. It is equally unreasonable to treat a laboratory origin as some fringe fantasy responsible people are forbidden to investigate. It isn't.

A Lab Accident Does Not Require an Engineered Virus

Another misconception deserves attention. People hear "lab leak" and picture scientists building SARS-CoV-2 from scratch. That is not necessary. WHO found no scientific evidence that SARS-CoV-2 was deliberately engineered, and its 2025 assessment said the genomic characteristics can be explained through natural mutation and recombination. But a laboratory-associated origin and a deliberately engineered virus are two different claims. Researchers routinely collect viruses from animals in the field. A naturally occurring virus could infect a researcher during collection. It could be brought into a lab and infect a worker there. A virus under study could escape without ever having been genetically manufactured.

"There is no proof SARS-CoV-2 was engineered" does not equal "there could not have been a laboratory accident." WHO itself treats an accidental research-related event as a separate hypothesis from deliberate manipulation. That distinction should have been made clear from the start.

The Question We Should Have Asked in 2020

The proper question was never whether we can prove China intentionally manufactured COVID. The proper question was what happened in Wuhan in the months before the first recognized cases. What viruses had been collected. Which were being cultured. Which were genetically modified. What experiments were underway. Which lab workers became sick. What safety incidents occurred. What databases existed before they went offline. What EcoHealth knew and when. What NIH knew and when. Whether every grant condition was followed. Whether unusual results were reported immediately. Whether lab notebooks, sequence databases and health records were preserved, and whether Chinese authorities gave investigators full access to them.

These are not partisan questions. They are basic investigative questions. And it is remarkable that six years after a pandemic that killed millions, WHO still says the information needed to answer some of them has not been provided.

What Has Really Become Flimsy

I would revise the common claim that the wet-market theory gets flimsier every day. Legitimate scientific evidence still supports natural spillover. What has become hard to defend is something else entirely. It is the early certainty that the wet-market explanation was settled and that seriously considering a lab accident was inherently irrational. It wasn't settled. It still isn't. WHO says so. The CIA says both possibilities remain plausible. Federal auditors documented serious problems in the oversight of American-funded research tied to Wuhan. GAO documented coronavirus genetic experiments at WIV. China still has not provided information WHO calls necessary to fully evaluate the laboratory hypothesis.

That is the story worth investigating. Not that Fauci created COVID. Not that China definitely engineered a bioweapon. Not that the raccoon dog definitely did it. The intellectually honest position is simpler than any of that. We do not yet know, and given what happened, "we do not know" is not a reason to stop digging. It is the reason to dig harder.

My Bottom Line

Fauci's statement that he could not guarantee researchers in Wuhan complied with the conditions attached to American funding is not, by itself, a confession. But it is enormously important in context. American money reached an institution conducting sophisticated coronavirus research. Federal investigators later documented inadequate monitoring. That research involved genetically altered bat coronaviruses. Special safety reporting provisions existed because of the risk. Those systems failed in meaningful ways. The pandemic began in the same city. China has withheld information international investigators say they need to determine whether a laboratory incident occurred. The origin remains unresolved.

At that point, demanding a comprehensive investigation is not conspiracy thinking. Failing to demand one would be irresponsible. Perhaps SARS-CoV-2 crossed naturally from an animal into a human. Perhaps the Huanan market played the decisive role. Perhaps a naturally occurring virus somehow became tied to laboratory research and escaped by accident. Perhaps evidence we have not seen yet will settle the question. But one position has aged particularly badly, and that is "don't ask." Science depends on questions. Government accountability depends on questions. Public trust depends on questions. After a pandemic that changed the world, we should be willing to ask every one of them.

Why This Matters

This is about far more than Anthony Fauci. It is about whether governments should fund potentially dangerous biological research in countries where they cannot independently inspect laboratories, verify records or enforce American safety standards. It is about whether scientific institutions get to investigate themselves after a catastrophe. It is about whether grant recipients can be trusted to police foreign subrecipients doing research capable of producing enormous public consequences. Most of all, it is about preventing the next pandemic. If COVID came from natural spillover, we need to understand animal trade, wildlife reservoirs and the pathways viruses use to reach human populations. If COVID came from a laboratory accident, we need stronger biosafety standards, transparency and international oversight. Either answer could save millions of lives someday.

Finding out what happened is not about settling an old political score. It is about making sure it never happens again.